Common fragile sites in colon cancer cell lines: Role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 712, Issue 1-2, 2011, Pages 40-48

  Vernole, Patrizia ^a   Muzi, Alessia ^a   Volpi, Antonio ^a   Terrinoni, Alessandro ^a   Dorio, Annalisa Susanna ^a   Tentori, Lucio ^a   Shah, Girish M ^b   Graziani, Grazia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Aphidicolin; Colon cancer; Common fragile sites; Mismatch repair; PARP 1; RAD51

Indexed keywords

APHIDICOLIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; RAD51 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CHROMOSOMAL INSTABILITY; CHROMOSOME 16Q; CHROMOSOME BREAKAGE; CHROMOSOME DAMAGE; CHROMOSOME FRAGILE SITE; COLON CANCER; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR SUPPRESSOR GENE; WWOX GENE;

CELL LINE, TUMOR; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITES; COLONIC NEOPLASMS; DNA MISMATCH REPAIR; GENE SILENCING; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; RAD51 RECOMBINASE;

EID: 79957700521     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.04.006     Document Type: Article

References (57)

1. Pichiorri F., Ishii H., Okumura H., Trapasso F., Wang Y., Huebner K. Molecular parameters of genome instability: roles of fragile genes at common fragile sites. J. Cell Biochem. 2008, 104:1525-1533.
2. Glover T.W., Berger C., Coyle J., Echo B. DNA polymerase α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 1984, 67:136-142.
3. Durkin S.G., Glover T.W. Chromosome fragile sites. Annu. Rev. Genet. 2007, 41:169-192.
4. Ohta M., Inonue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T., Croce C.M., Huebner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84:587-597.
5. Ried K., Finnis M., Hobson L., Mangeldorf M., Sayan S., Nancarrow J.K., Woollatt E., Kremmidiotis G., Gardner A., Venter D., Baker E., Richards L.R. Common fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet. 2000, 9:1651-1663.
6. Kuwano A., Murano I., Kajii T. Cell type-dependent difference in the distribution and frequency of excess thymidine-induced common fragile sites: T lymphocytes and skin fibroblasts. Hum. Genet. 1990, 84:527-531.
7. Caporossi D., Vernole P., Nicoletti B., Tedeschi B. Characteristic chromosomal fragility of human embryonic cells exposed in vitro to aphidicolin. Hum. Genet. 1995, 96:269-274.
8. Letessier A., Millot G.A., Koundrioukoff S., Lachagès A.M., Vogt N., Hansen R.S., Malfoy B., Brison O., Debatisse M. Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 2011, 470:120-123.
9. Casper A.M., Nghiem P., Arlt M.F., Glover T.W. ATR regulates fragile site stability. Cell 2002, 111:779-789.
10. Schwartz M., Zlotorynski E., Goldberg M., Ozeri E., Rahat A., le Sage C., Chen B.P., Chen D.J., Agami R., Kerem B. Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev. 2005, 19:2715-2726.
11. Wan C., Kulkarni A., Wang Y.H. ATR preferentially interacts with common fragile site FRA3B and the binding requires its kinase activity in response to aphidicolin treatment. Mutat. Res. 2010, 686:39-46.
12. Rothkamm K., Krüger I., Thompson L.H., Löbrich M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol. Cell Biol. 2003, 23:5706-5715.
13. Jiricny J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 2006, 7:335-346.
14. Vernole P., Muzi A., Volpi A., Dorio A.S., Terrinoni A., Shah G.M., Graziani G. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells. Mutat. Res. 2009, 664:39-47.
15. Barwell J., Pangon L., Hodgson S., Georgiou A., Kesterton I., Slade T., Taylor M., Payne S.J., Brinkman H., Smythe J., Sebire N.J., Solomon E., Docherty Z., Camplejohn R., Homfray T., Morris J.R. Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics. J. Med. Genet. 2007, 44:516-520.
16. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 1995, 82:321-330.
17. Pichierri P., Franchitto A., Piergentili R., Colussi C., Palitti F. Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair. Carcinogenesis 2001, 22:1781-1787.
18. Elliott B., Jasin M. Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cells. Mol. Cell Biol. 2001, 21:2671-2682.
19. Marsischky G.T., Lee S., Griffith J., Kolodner R.D. Saccharomyces cerevisiae MSH2/6 complex interacts with Holliday junctions and facilitates their cleavage by phage resolution enzymes. J. Biol. Chem. 1999, 274:7200-7206.
20. Vilar E., Gruber S.B. Microsatellite instability in colorectal cancer-the stable evidence. Nat. Rev. Clin. Oncol. 2010, 7:153-162.
21. Hassa P.O., Hottiger M.O. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front. Biosci. 2008, 13:3046-3082.
22. Wang M., Wu W., Wu W., Rosidi B., Zhang L., Wang H., Iliakis G. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res. 2006, 34:6170-6182.
23. Sugimura K., Takebayashi S., Taguchi H., Takeda S., Okumura K. PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA. J. Cell Biol. 2008, 183:1203-1212.
24. Umar A., Koi M., Risinger J.I., Glaab W.E., Tindall K.R., Kolodner R.D., Boland C.R., Barrett J.C., Kunkel T.A. Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res. 1997, 57:3949-3955.
25. Lettieri T., Marra G., Aquilina G., Bignami M., Crompton N.E., Palombo F., Jiricny J. Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15. Carcinogenesis 1999, 20:373-382.
26. Papadopoulos N., Nicoladesi N.C., Wei Y.F., Ruben S.M., Carte K.C., Rosen C.A., Haseltine W.A., Fleishmann R.D., Fraser C.M., Adams M.D., Venter J.C., Hamilton S.R., Petersen P., Watson G.M., Lynch H.T., Peltomaki P., Mecklin J.P., de la Chapelle A., Kinzler K.W., Vogelstein B. Mutation of a MutL homolog in hereditary colon cancer. Science 1994, 263:1625-1629.
27. Koi M., Umar A., Chaulan D.P., Cherian S.P., Carethers J.M., Kunkel T.A., Boland C.R. Human chromosome 3 corrects mismatch deficiency and microsatellite instability and reduces N-methyl-N′-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res. 1994, 54:4308-4312.
28. Aquilina G., Ceccotti S., Martinelli S., Hampson R., Bignami M. N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells. Cancer Res. 1998, 58:135-141.
29. Kleivi K., Teixeira M.R., Eknaes M., Diep C.B., Jakobsen K.S., Hamelin R., Lothe R.A. Genome signatures of colon carcinoma cell lines. Cancer Genet. Cytogenet. 2004, 155:119-131.
30. Rutzky L.P., Kaye C.I., Siciliano M.J., Chao M., Kahan B.D. Longitudinal karyotype and genetic signature analysis of cultured human colon adenocarcinoma cell lines LS180 and LS174T. Cancer Res. 1980, 40:1443-1448.
31. Goldmacher V.S., Cuzick R.A., Thilly W.G. Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine. J. Biol. Chem. 1986, 261:12462-12471.
32. Szadkowski M., Iaccarino I., Heinimann K., Marra G., Jiricny J. Characterization of the mismatch repair defect in the human lymphoblastoid MT1 cells. Cancer Res. 2005, 65:4525-4529.
33. Vernole P., Tedeschi B., Tentori L., Levati L., Argentin G., Cicchetti R., Forini O., Graziani G., D'Atri S. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin. Mutat. Res. 2006, 594:63-77.
34. Vernole P., Pepponi R., D'Atri S. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents. Cancer Chemother. Pharmacol. 2003, 52:185-192.
35. Mariani T. Fragile sites and statistics. Hum. Genet. 1989, 81:319-322.
36. Shah R.G., Ghodgaonkar M.M., Affar el B., Shah G.M. DNA vector-based RNAi approach for stable depletion of poly(ADP-ribose) polymerase-1. Biochem. Biophys. Res. Commun. 2005, 331:167-174.
37. MacPhail S.H., Banáth J.P., Yu Y., Chu E., Olive P.L. Cell cycle-dependent expression of phosphorylated histone H2AX: reduced expression in unirradiated but not X-irradiated G1-phase cells. Radiat. Res. 2003, 159:759-767.
38. Stojic L., Brun R., Jiricny J. Mismatch repair and DNA damage signalling. DNA Repair 2004, 3:1091-1101.
39. Tedeschi B., Vernole P., Sanna M.L., Nicoletti B. Population cytogenetics of aphidicolin-induced fragile sites. Hum. Genet. 1992, 89:543-547.
40. Austin M.J., Collins J.M., Corey L.A., Nance W.E., Neale M.C., Schieken R.M., Brown J.A. Aphidicolin-inducible common fragile-site expression: results from a population survey of twins. Am. J. Hum. Genet. 1992, 50:76-83.
41. Sonoda E., Sasaki M.S., Buerstedde J.M., Bezzubova O., Shinohara A., Ogawa H., Takata M., Yamaguchi-Iwai Y., Takeda S. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 1998, 17:598-608.
42. Finnis M., Dayan S., Hobson L., Chenevix-Trench G., Friend K., Ried K., Venter D., Woollatt E., Baker E., Richards R.I. Common chromosomal fragile site FRA16D mutation in cancer cells. Hum. Mol. Genet. 2005, 14:1341-1349.
43. Paige A.J., Taylor K.J., Stewart A., Sgouros J.G., Gabra H., Sellar G.C., Smyth J.F., Porteous D.J., Watson J.E. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res. 2000, 60:1690-1697.
44. Ludes-Meyers J.H., Bednarek A.K., Popescu N.C., Bedford M., Aldaz C.M. WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenet. Genome Res. 2003, 100:101-110.
45. Alsop A.E., Taylor K., Zhang J., Gabra H.A.J., Paige P.A. Edwards Homozygous deletions may be markers of nearby heterozygous mutations: the complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX. Genes Chromosomes Cancer 2008, 47:437-447.
46. Arlt M.F., Glover T.W. Inhibition of topoisomerase I prevents chromosome breakage at common fragile sites. DNA Repair (Amst.) 2010, 9:678-689.
47. Takahashi T., Min Z., Uchida I., Arita M., Watanabe Y., Koi M., Hemmi H. Hypersensitivity in DNA mismatch repair-deficient colon carcinoma cells to DNA polymerase reaction inhibitors. Cancer Lett. 2005, 220:85-93.
48. Turner B.C., Ottey M., Zimonjic D.B., Potoczek M., Hauck W.W., Pequignot E., Keck-Waggoner C.L., Sevignani C., Aldaz C.M., McCue P.A., Palazzo J., Huebner K., Popescu N.C. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers. Cancer Res. 2002, 62:4054-4060.
49. Moreland N.J., Illand M., Kim Y.T., Paul J., Brown R. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin. Cancer Res. 1999, 59:2102-2106.
50. Yang Q., Zhang R., Wang X.W., Linke S.P., Sengupta S., Hickson I.D., Pedrazzi G., Perrera C., Stagljar I., Littman S.J., Modrich P., Harris C.C. The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase. Oncogene 2004, 23:3749-3756.
51. Mojas N., Lopes M., Jiricny J. Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA. Genes Dev. 2007, 21:3342-3355.
52. Modrich P., Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 1996, 65:101-133.
53. Mohindra A., Hays L.E., Phillips E.N., Preston B.D., Helleday T., Meuth M. Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines. Hum. Mol. Genet. 2002, 11:2189-2200.
54. Schwarz V.A., Hornung R., Fedier A., Fehr M.K., Walt H., Haller U., Fink D. Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells. Br. J. Cancer. 2002, 86:1130-1135.
55. Lavoie J., Carter R., Drouin R., Lebel M. Increased frequency of multiradial chromosome structures in mouse embryonic fibroblasts lacking functional Werner syndrome protein and poly(ADP-ribose) polymerase-1. Cancer Genet. Cytogenet. 2005, 156:134-143.
56. Hochegger H., Dejsuphong D., Fukushima T., Morrison C., Sonoda E., Schreiber V., Zhao G.Y., Saberi A., Masutani M., Adachi N., Koyama H., de Murcia G., Takeda S. Parp-1 protects homologous recombination from interference by Ku and Ligase IV in vertebrate cells. EMBO J. 2006, 25:1305-1314.
57. Campisi Hegan D., Lu Y., Stachelek G.C., Crosby M.E., Bindra R.S., Glazer P.M. Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc. Natl. Acad. Sci. U.S.A. 2010, 107. 2201-2006.